PANCREATIC ADENOCARCINOMA METASTATIC
Clinical trials for PANCREATIC ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tackle deadly pancreatic cancer
Disease control Not yet recruitingThis study tests a new drug called samuraciclib added to standard chemotherapy for people with a specific type of advanced pancreatic cancer (basal-like). The goal is to find the safest dose and see if the combination helps shrink tumors or slow the cancer. About 67 adults with n…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new drug combination (L19IL2 plus ruxolitinib) in people with advanced kidney, pancreatic, or colorectal cancers that have stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. About 96 partici…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Sound waves boost chemo to fight liver tumors in pancreatic cancer patients
Disease control Not yet recruitingThis early-phase study tests a new approach for people with pancreatic cancer that has spread to the liver and who have already tried standard chemotherapy. The treatment combines standard chemotherapy drugs with a special ultrasound technique that uses tiny bubbles to help deliv…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New study tests if tumor genes and organoids can outsmart pancreatic cancer
Knowledge-focused Not yet recruitingThis observational study will enroll 185 people with metastatic pancreatic cancer to see if analyzing tumor genes and lab-grown organoids can predict which standard chemotherapy regimens work best. Researchers will compare predicted drug sensitivity to actual patient outcomes. Th…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Sponsor: Prof. Dr. med. Dres. h.c. Jan Schmidt, MME • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC